nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—CYP2D6—Lomustine—brain cancer	0.116	0.303	CbGbCtD
Maprotiline—CYP1A2—Carmustine—brain cancer	0.115	0.3	CbGbCtD
Maprotiline—CYP2D6—Hydroxyurea—brain cancer	0.0882	0.23	CbGbCtD
Maprotiline—CYP1A2—Etoposide—brain cancer	0.0341	0.089	CbGbCtD
Maprotiline—ABCB1—Etoposide—brain cancer	0.0298	0.0778	CbGbCtD
Maprotiline—HTR2C—choroid plexus—brain cancer	0.022	0.0901	CbGeAlD
Maprotiline—HTR2A—choroid plexus—brain cancer	0.011	0.0452	CbGeAlD
Maprotiline—HRH1—nose—brain cancer	0.00852	0.0349	CbGeAlD
Maprotiline—HTR7—vein—brain cancer	0.00809	0.0331	CbGeAlD
Maprotiline—SLC6A3—telencephalic ventricle—brain cancer	0.00667	0.0273	CbGeAlD
Maprotiline—HTR2C—telencephalic ventricle—brain cancer	0.00645	0.0264	CbGeAlD
Maprotiline—HTR7—cranial nerve—brain cancer	0.00638	0.0261	CbGeAlD
Maprotiline—HTR7—pons—brain cancer	0.00631	0.0258	CbGeAlD
Maprotiline—HTR2A—trigeminal nerve—brain cancer	0.00558	0.0229	CbGeAlD
Maprotiline—HTR2A—cerebellar cortex—brain cancer	0.00556	0.0228	CbGeAlD
Maprotiline—Sertraline—CYP2C9—brain cancer	0.0052	0.82	CrCbGaD
Maprotiline—HTR7—telencephalic ventricle—brain cancer	0.00519	0.0212	CbGeAlD
Maprotiline—HTR2A—vein—brain cancer	0.00505	0.0207	CbGeAlD
Maprotiline—DRD2—telencephalic ventricle—brain cancer	0.00491	0.0201	CbGeAlD
Maprotiline—SLC6A3—ganglion—brain cancer	0.00415	0.017	CbGeAlD
Maprotiline—HTR2C—ganglion—brain cancer	0.00402	0.0164	CbGeAlD
Maprotiline—HTR2A—cranial nerve—brain cancer	0.00398	0.0163	CbGeAlD
Maprotiline—HTR2A—pons—brain cancer	0.00393	0.0161	CbGeAlD
Maprotiline—SLC6A2—ganglion—brain cancer	0.00335	0.0137	CbGeAlD
Maprotiline—HTR2A—telencephalic ventricle—brain cancer	0.00324	0.0132	CbGeAlD
Maprotiline—HTR7—ganglion—brain cancer	0.00323	0.0132	CbGeAlD
Maprotiline—SLC6A3—hindbrain—brain cancer	0.00315	0.0129	CbGeAlD
Maprotiline—DRD2—ganglion—brain cancer	0.00305	0.0125	CbGeAlD
Maprotiline—HTR2A—pineal body—brain cancer	0.00281	0.0115	CbGeAlD
Maprotiline—HTR7—endothelium—brain cancer	0.00278	0.0114	CbGeAlD
Maprotiline—HTR7—blood vessel—brain cancer	0.00257	0.0105	CbGeAlD
Maprotiline—HTR7—hindbrain—brain cancer	0.00245	0.01	CbGeAlD
Maprotiline—DRD2—hindbrain—brain cancer	0.00232	0.00948	CbGeAlD
Maprotiline—HTR2A—ganglion—brain cancer	0.00201	0.00825	CbGeAlD
Maprotiline—CHRM4—head—brain cancer	0.00187	0.00764	CbGeAlD
Maprotiline—SLC6A3—brainstem—brain cancer	0.00181	0.00739	CbGeAlD
Maprotiline—HTR2C—brainstem—brain cancer	0.00175	0.00715	CbGeAlD
Maprotiline—HTR2A—endothelium—brain cancer	0.00174	0.00711	CbGeAlD
Maprotiline—CHRM4—central nervous system—brain cancer	0.0017	0.00697	CbGeAlD
Maprotiline—CHRM2—telencephalon—brain cancer	0.00161	0.00658	CbGeAlD
Maprotiline—SLC6A3—telencephalon—brain cancer	0.0016	0.00656	CbGeAlD
Maprotiline—HTR2A—blood vessel—brain cancer	0.0016	0.00656	CbGeAlD
Maprotiline—HTR2C—telencephalon—brain cancer	0.00155	0.00634	CbGeAlD
Maprotiline—HTR2A—hindbrain—brain cancer	0.00153	0.00625	CbGeAlD
Maprotiline—CHRM1—telencephalon—brain cancer	0.00146	0.00599	CbGeAlD
Maprotiline—CHRM5—head—brain cancer	0.00146	0.00597	CbGeAlD
Maprotiline—SLC6A2—brainstem—brain cancer	0.00146	0.00596	CbGeAlD
Maprotiline—HTR7—brainstem—brain cancer	0.0014	0.00575	CbGeAlD
Maprotiline—CYP2D6—hindbrain—brain cancer	0.00139	0.0057	CbGeAlD
Maprotiline—CHRM4—brain—brain cancer	0.00135	0.00553	CbGeAlD
Maprotiline—CHRM5—central nervous system—brain cancer	0.00133	0.00545	CbGeAlD
Maprotiline—DRD2—brainstem—brain cancer	0.00133	0.00543	CbGeAlD
Maprotiline—Menopausal symptoms—Temozolomide—brain cancer	0.00132	0.0044	CcSEcCtD
Maprotiline—CHRM3—telencephalon—brain cancer	0.00131	0.00536	CbGeAlD
Maprotiline—Pancytopenia—Hydroxyurea—brain cancer	0.0013	0.00436	CcSEcCtD
Maprotiline—SLC6A2—telencephalon—brain cancer	0.00129	0.00529	CbGeAlD
Maprotiline—Purpura—Temozolomide—brain cancer	0.00129	0.0043	CcSEcCtD
Maprotiline—Arrhythmia—Procarbazine—brain cancer	0.00127	0.00424	CcSEcCtD
Maprotiline—Body temperature increased—Lomustine—brain cancer	0.00126	0.0042	CcSEcCtD
Maprotiline—Alopecia—Procarbazine—brain cancer	0.00126	0.00419	CcSEcCtD
Maprotiline—Weight increased—Hydroxyurea—brain cancer	0.00125	0.00418	CcSEcCtD
Maprotiline—HTR7—telencephalon—brain cancer	0.00125	0.0051	CbGeAlD
Maprotiline—Infestation NOS—Hydroxyurea—brain cancer	0.00122	0.00409	CcSEcCtD
Maprotiline—Drowsiness—Hydroxyurea—brain cancer	0.00122	0.00409	CcSEcCtD
Maprotiline—Infestation—Hydroxyurea—brain cancer	0.00122	0.00409	CcSEcCtD
Maprotiline—HTR2C—medulla oblongata—brain cancer	0.00122	0.00498	CbGeAlD
Maprotiline—Tension—Procarbazine—brain cancer	0.00121	0.00405	CcSEcCtD
Maprotiline—Ataxia—Carmustine—brain cancer	0.00121	0.00404	CcSEcCtD
Maprotiline—ORM1—spinal cord—brain cancer	0.00121	0.00494	CbGeAlD
Maprotiline—Nervousness—Procarbazine—brain cancer	0.0012	0.00401	CcSEcCtD
Maprotiline—Neuropathy peripheral—Hydroxyurea—brain cancer	0.0012	0.00401	CcSEcCtD
Maprotiline—Stomatitis—Hydroxyurea—brain cancer	0.00119	0.00399	CcSEcCtD
Maprotiline—Liver function test abnormal—Carmustine—brain cancer	0.00119	0.00396	CcSEcCtD
Maprotiline—DRD2—telencephalon—brain cancer	0.00118	0.00482	CbGeAlD
Maprotiline—Ataxia—Temozolomide—brain cancer	0.00117	0.0039	CcSEcCtD
Maprotiline—Tremor—Procarbazine—brain cancer	0.00116	0.00387	CcSEcCtD
Maprotiline—Hepatobiliary disease—Hydroxyurea—brain cancer	0.00116	0.00387	CcSEcCtD
Maprotiline—SLC6A3—midbrain—brain cancer	0.00115	0.00471	CbGeAlD
Maprotiline—Nortriptyline—CYP2C9—brain cancer	0.00114	0.18	CrCbGaD
Maprotiline—Muscular weakness—Carmustine—brain cancer	0.00113	0.00378	CcSEcCtD
Maprotiline—SLC6A3—spinal cord—brain cancer	0.00112	0.0046	CbGeAlD
Maprotiline—Breast disorder—Temozolomide—brain cancer	0.00112	0.00375	CcSEcCtD
Maprotiline—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.00112	0.00373	CcSEcCtD
Maprotiline—HTR2C—midbrain—brain cancer	0.00111	0.00455	CbGeAlD
Maprotiline—Dysphagia—Carmustine—brain cancer	0.00111	0.00371	CcSEcCtD
Maprotiline—Syncope—Procarbazine—brain cancer	0.00111	0.0037	CcSEcCtD
Maprotiline—Leukopenia—Procarbazine—brain cancer	0.00111	0.0037	CcSEcCtD
Maprotiline—Muscular weakness—Temozolomide—brain cancer	0.0011	0.00366	CcSEcCtD
Maprotiline—Hallucination—Hydroxyurea—brain cancer	0.00109	0.00365	CcSEcCtD
Maprotiline—Loss of consciousness—Procarbazine—brain cancer	0.00109	0.00363	CcSEcCtD
Maprotiline—ORM1—endocrine gland—brain cancer	0.00109	0.00445	CbGeAlD
Maprotiline—HTR2C—spinal cord—brain cancer	0.00109	0.00444	CbGeAlD
Maprotiline—SLC6A2—gonad—brain cancer	0.00108	0.00442	CbGeAlD
Maprotiline—Dysphagia—Temozolomide—brain cancer	0.00107	0.00358	CcSEcCtD
Maprotiline—Convulsion—Procarbazine—brain cancer	0.00107	0.00358	CcSEcCtD
Maprotiline—Hypertension—Procarbazine—brain cancer	0.00107	0.00357	CcSEcCtD
Maprotiline—CHRM5—brain—brain cancer	0.00106	0.00432	CbGeAlD
Maprotiline—Pancytopenia—Carmustine—brain cancer	0.00105	0.00352	CcSEcCtD
Maprotiline—ABCB1—blood vessel—brain cancer	0.00105	0.0043	CbGeAlD
Maprotiline—Anxiety—Procarbazine—brain cancer	0.00105	0.0035	CcSEcCtD
Maprotiline—Sweating increased—Temozolomide—brain cancer	0.00105	0.00349	CcSEcCtD
Maprotiline—HTR7—gonad—brain cancer	0.00104	0.00426	CbGeAlD
Maprotiline—Dry mouth—Procarbazine—brain cancer	0.00103	0.00344	CcSEcCtD
Maprotiline—Pancytopenia—Temozolomide—brain cancer	0.00102	0.0034	CcSEcCtD
Maprotiline—Confusional state—Procarbazine—brain cancer	0.00102	0.0034	CcSEcCtD
Maprotiline—SLC6A2—medulla oblongata—brain cancer	0.00102	0.00416	CbGeAlD
Maprotiline—CHRM2—endocrine gland—brain cancer	0.00101	0.00415	CbGeAlD
Maprotiline—Vomiting—Lomustine—brain cancer	0.00101	0.00338	CcSEcCtD
Maprotiline—Oedema—Procarbazine—brain cancer	0.00101	0.00337	CcSEcCtD
Maprotiline—Infection—Procarbazine—brain cancer	0.001	0.00335	CcSEcCtD
Maprotiline—CHRM2—head—brain cancer	0.001	0.0041	CbGeAlD
Maprotiline—SLC6A3—head—brain cancer	0.000998	0.00408	CbGeAlD
Maprotiline—Angiopathy—Hydroxyurea—brain cancer	0.000998	0.00333	CcSEcCtD
Maprotiline—Shock—Procarbazine—brain cancer	0.000993	0.00332	CcSEcCtD
Maprotiline—Pollakiuria—Temozolomide—brain cancer	0.000991	0.00331	CcSEcCtD
Maprotiline—Erectile dysfunction—Temozolomide—brain cancer	0.000988	0.0033	CcSEcCtD
Maprotiline—Thrombocytopenia—Procarbazine—brain cancer	0.000988	0.0033	CcSEcCtD
Maprotiline—Tachycardia—Procarbazine—brain cancer	0.000985	0.00329	CcSEcCtD
Maprotiline—Photosensitivity reaction—Temozolomide—brain cancer	0.00098	0.00327	CcSEcCtD
Maprotiline—ORM1—central nervous system—brain cancer	0.000979	0.00401	CbGeAlD
Maprotiline—HTR7—medulla oblongata—brain cancer	0.000979	0.00401	CbGeAlD
Maprotiline—Weight increased—Temozolomide—brain cancer	0.000977	0.00326	CcSEcCtD
Maprotiline—Hyperhidrosis—Procarbazine—brain cancer	0.000976	0.00326	CcSEcCtD
Maprotiline—Alopecia—Hydroxyurea—brain cancer	0.000972	0.00325	CcSEcCtD
Maprotiline—Weight decreased—Temozolomide—brain cancer	0.000971	0.00324	CcSEcCtD
Maprotiline—Neuropathy peripheral—Carmustine—brain cancer	0.000971	0.00324	CcSEcCtD
Maprotiline—Stomatitis—Carmustine—brain cancer	0.000965	0.00322	CcSEcCtD
Maprotiline—HTR2C—head—brain cancer	0.000964	0.00395	CbGeAlD
Maprotiline—DRD2—pituitary gland—brain cancer	0.000959	0.00393	CbGeAlD
Maprotiline—Infestation NOS—Temozolomide—brain cancer	0.000957	0.0032	CcSEcCtD
Maprotiline—Infestation—Temozolomide—brain cancer	0.000957	0.0032	CcSEcCtD
Maprotiline—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000949	0.00317	CcSEcCtD
Maprotiline—Nausea—Lomustine—brain cancer	0.000944	0.00315	CcSEcCtD
Maprotiline—Hypotension—Procarbazine—brain cancer	0.000943	0.00315	CcSEcCtD
Maprotiline—Neuropathy peripheral—Temozolomide—brain cancer	0.000938	0.00313	CcSEcCtD
Maprotiline—Stomatitis—Temozolomide—brain cancer	0.000933	0.00312	CcSEcCtD
Maprotiline—HRH1—telencephalon—brain cancer	0.00093	0.00381	CbGeAlD
Maprotiline—CHRM1—endocrine gland—brain cancer	0.000923	0.00378	CbGeAlD
Maprotiline—CHRM2—central nervous system—brain cancer	0.000913	0.00374	CbGeAlD
Maprotiline—Insomnia—Procarbazine—brain cancer	0.000913	0.00305	CcSEcCtD
Maprotiline—CHRM1—head—brain cancer	0.000911	0.00373	CbGeAlD
Maprotiline—SLC6A3—central nervous system—brain cancer	0.000911	0.00373	CbGeAlD
Maprotiline—Paraesthesia—Procarbazine—brain cancer	0.000906	0.00303	CcSEcCtD
Maprotiline—Hepatobiliary disease—Temozolomide—brain cancer	0.000905	0.00302	CcSEcCtD
Maprotiline—Somnolence—Procarbazine—brain cancer	0.000897	0.003	CcSEcCtD
Maprotiline—HTR7—midbrain—brain cancer	0.000895	0.00366	CbGeAlD
Maprotiline—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000895	0.00299	CcSEcCtD
Maprotiline—SLC6A3—cerebellum—brain cancer	0.00089	0.00364	CbGeAlD
Maprotiline—Hallucination—Carmustine—brain cancer	0.000884	0.00295	CcSEcCtD
Maprotiline—Hypoaesthesia—Carmustine—brain cancer	0.000884	0.00295	CcSEcCtD
Maprotiline—HTR2C—central nervous system—brain cancer	0.00088	0.0036	CbGeAlD
Maprotiline—HTR2A—brainstem—brain cancer	0.000875	0.00358	CbGeAlD
Maprotiline—HTR7—spinal cord—brain cancer	0.000873	0.00357	CbGeAlD
Maprotiline—Fatigue—Procarbazine—brain cancer	0.00087	0.00291	CcSEcCtD
Maprotiline—Constipation—Procarbazine—brain cancer	0.000863	0.00288	CcSEcCtD
Maprotiline—Hepatitis—Temozolomide—brain cancer	0.000859	0.00287	CcSEcCtD
Maprotiline—Dysphagia—Etoposide—brain cancer	0.000859	0.00287	CcSEcCtD
Maprotiline—Leukopenia—Hydroxyurea—brain cancer	0.000857	0.00286	CcSEcCtD
Maprotiline—Hallucination—Temozolomide—brain cancer	0.000855	0.00285	CcSEcCtD
Maprotiline—Hypoaesthesia—Temozolomide—brain cancer	0.000855	0.00285	CcSEcCtD
Maprotiline—Urinary tract disorder—Temozolomide—brain cancer	0.000848	0.00283	CcSEcCtD
Maprotiline—DRD2—midbrain—brain cancer	0.000846	0.00346	CbGeAlD
Maprotiline—Bronchospasm—Etoposide—brain cancer	0.000845	0.00282	CcSEcCtD
Maprotiline—Urethral disorder—Temozolomide—brain cancer	0.000842	0.00281	CcSEcCtD
Maprotiline—Sweating increased—Etoposide—brain cancer	0.000836	0.00279	CcSEcCtD
Maprotiline—Feeling abnormal—Procarbazine—brain cancer	0.000832	0.00278	CcSEcCtD
Maprotiline—CHRM1—central nervous system—brain cancer	0.000831	0.0034	CbGeAlD
Maprotiline—Eye disorder—Carmustine—brain cancer	0.000831	0.00277	CcSEcCtD
Maprotiline—Convulsion—Hydroxyurea—brain cancer	0.000829	0.00277	CcSEcCtD
Maprotiline—CHRM3—endocrine gland—brain cancer	0.000826	0.00338	CbGeAlD
Maprotiline—Gastrointestinal pain—Procarbazine—brain cancer	0.000825	0.00276	CcSEcCtD
Maprotiline—Flushing—Carmustine—brain cancer	0.000825	0.00276	CcSEcCtD
Maprotiline—Pancytopenia—Etoposide—brain cancer	0.000816	0.00272	CcSEcCtD
Maprotiline—SLC6A2—endocrine gland—brain cancer	0.000815	0.00334	CbGeAlD
Maprotiline—CHRM3—head—brain cancer	0.000815	0.00334	CbGeAlD
Maprotiline—Erythema multiforme—Temozolomide—brain cancer	0.000812	0.00271	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000809	0.0027	CcSEcCtD
Maprotiline—SLC6A2—head—brain cancer	0.000805	0.0033	CbGeAlD
Maprotiline—Eye disorder—Temozolomide—brain cancer	0.000803	0.00268	CcSEcCtD
Maprotiline—Urticaria—Procarbazine—brain cancer	0.000802	0.00268	CcSEcCtD
Maprotiline—Tinnitus—Temozolomide—brain cancer	0.000801	0.00267	CcSEcCtD
Maprotiline—Abdominal pain—Procarbazine—brain cancer	0.000798	0.00267	CcSEcCtD
Maprotiline—Body temperature increased—Procarbazine—brain cancer	0.000798	0.00267	CcSEcCtD
Maprotiline—CYP2D6—brainstem—brain cancer	0.000798	0.00327	CbGeAlD
Maprotiline—Flushing—Temozolomide—brain cancer	0.000797	0.00266	CcSEcCtD
Maprotiline—Cardiac disorder—Temozolomide—brain cancer	0.000797	0.00266	CcSEcCtD
Maprotiline—Arrhythmia—Carmustine—brain cancer	0.000794	0.00265	CcSEcCtD
Maprotiline—HTR7—endocrine gland—brain cancer	0.000786	0.00322	CbGeAlD
Maprotiline—Alopecia—Carmustine—brain cancer	0.000785	0.00262	CcSEcCtD
Maprotiline—Oedema—Hydroxyurea—brain cancer	0.000781	0.00261	CcSEcCtD
Maprotiline—Angiopathy—Temozolomide—brain cancer	0.000779	0.0026	CcSEcCtD
Maprotiline—HTR2A—telencephalon—brain cancer	0.000777	0.00318	CbGeAlD
Maprotiline—Infection—Hydroxyurea—brain cancer	0.000776	0.00259	CcSEcCtD
Maprotiline—HTR7—head—brain cancer	0.000776	0.00318	CbGeAlD
Maprotiline—Mediastinal disorder—Temozolomide—brain cancer	0.000774	0.00259	CcSEcCtD
Maprotiline—Malnutrition—Carmustine—brain cancer	0.000774	0.00258	CcSEcCtD
Maprotiline—Nervous system disorder—Hydroxyurea—brain cancer	0.000766	0.00256	CcSEcCtD
Maprotiline—Infestation NOS—Etoposide—brain cancer	0.000766	0.00256	CcSEcCtD
Maprotiline—Infestation—Etoposide—brain cancer	0.000766	0.00256	CcSEcCtD
Maprotiline—Thrombocytopenia—Hydroxyurea—brain cancer	0.000765	0.00255	CcSEcCtD
Maprotiline—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000759	0.00254	CcSEcCtD
Maprotiline—Alopecia—Temozolomide—brain cancer	0.000759	0.00254	CcSEcCtD
Maprotiline—Skin disorder—Hydroxyurea—brain cancer	0.000759	0.00253	CcSEcCtD
Maprotiline—Acute coronary syndrome—Etoposide—brain cancer	0.000755	0.00252	CcSEcCtD
Maprotiline—Myocardial infarction—Etoposide—brain cancer	0.000751	0.00251	CcSEcCtD
Maprotiline—Neuropathy peripheral—Etoposide—brain cancer	0.000751	0.00251	CcSEcCtD
Maprotiline—Malnutrition—Temozolomide—brain cancer	0.000748	0.0025	CcSEcCtD
Maprotiline—Jaundice—Etoposide—brain cancer	0.000746	0.00249	CcSEcCtD
Maprotiline—Stomatitis—Etoposide—brain cancer	0.000746	0.00249	CcSEcCtD
Maprotiline—CHRM3—central nervous system—brain cancer	0.000744	0.00305	CbGeAlD
Maprotiline—DRD2—endocrine gland—brain cancer	0.000743	0.00304	CbGeAlD
Maprotiline—SLC6A2—central nervous system—brain cancer	0.000735	0.00301	CbGeAlD
Maprotiline—DRD2—head—brain cancer	0.000734	0.003	CbGeAlD
Maprotiline—Dysgeusia—Temozolomide—brain cancer	0.000732	0.00245	CcSEcCtD
Maprotiline—Vision blurred—Carmustine—brain cancer	0.000729	0.00244	CcSEcCtD
Maprotiline—CHRM2—brain—brain cancer	0.000725	0.00297	CbGeAlD
Maprotiline—Tremor—Carmustine—brain cancer	0.000725	0.00242	CcSEcCtD
Maprotiline—Asthenia—Procarbazine—brain cancer	0.000724	0.00242	CcSEcCtD
Maprotiline—Hepatobiliary disease—Etoposide—brain cancer	0.000724	0.00242	CcSEcCtD
Maprotiline—SLC6A3—brain—brain cancer	0.000723	0.00296	CbGeAlD
Maprotiline—Agranulocytosis—Etoposide—brain cancer	0.000715	0.00239	CcSEcCtD
Maprotiline—Pruritus—Procarbazine—brain cancer	0.000714	0.00239	CcSEcCtD
Maprotiline—Agitation—Carmustine—brain cancer	0.000711	0.00237	CcSEcCtD
Maprotiline—HTR7—central nervous system—brain cancer	0.000708	0.0029	CbGeAlD
Maprotiline—CYP2D6—telencephalon—brain cancer	0.000708	0.0029	CbGeAlD
Maprotiline—Vision blurred—Temozolomide—brain cancer	0.000705	0.00235	CcSEcCtD
Maprotiline—Tremor—Temozolomide—brain cancer	0.000701	0.00234	CcSEcCtD
Maprotiline—HTR2C—brain—brain cancer	0.000699	0.00286	CbGeAlD
Maprotiline—Somnolence—Hydroxyurea—brain cancer	0.000694	0.00232	CcSEcCtD
Maprotiline—Leukopenia—Carmustine—brain cancer	0.000693	0.00231	CcSEcCtD
Maprotiline—HTR7—cerebellum—brain cancer	0.000692	0.00283	CbGeAlD
Maprotiline—Diarrhoea—Procarbazine—brain cancer	0.000691	0.00231	CcSEcCtD
Maprotiline—Dyspepsia—Hydroxyurea—brain cancer	0.000688	0.0023	CcSEcCtD
Maprotiline—Agitation—Temozolomide—brain cancer	0.000687	0.0023	CcSEcCtD
Maprotiline—Hypoaesthesia—Etoposide—brain cancer	0.000684	0.00228	CcSEcCtD
Maprotiline—Urinary tract disorder—Etoposide—brain cancer	0.000679	0.00227	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000674	0.00225	CcSEcCtD
Maprotiline—Urethral disorder—Etoposide—brain cancer	0.000674	0.00225	CcSEcCtD
Maprotiline—Fatigue—Hydroxyurea—brain cancer	0.000673	0.00225	CcSEcCtD
Maprotiline—Convulsion—Carmustine—brain cancer	0.00067	0.00224	CcSEcCtD
Maprotiline—DRD2—central nervous system—brain cancer	0.00067	0.00274	CbGeAlD
Maprotiline—Leukopenia—Temozolomide—brain cancer	0.000669	0.00224	CcSEcCtD
Maprotiline—Hypertension—Carmustine—brain cancer	0.000668	0.00223	CcSEcCtD
Maprotiline—Constipation—Hydroxyurea—brain cancer	0.000668	0.00223	CcSEcCtD
Maprotiline—Dizziness—Procarbazine—brain cancer	0.000667	0.00223	CcSEcCtD
Maprotiline—Palpitations—Temozolomide—brain cancer	0.000661	0.00221	CcSEcCtD
Maprotiline—CHRM1—brain—brain cancer	0.00066	0.0027	CbGeAlD
Maprotiline—Anxiety—Carmustine—brain cancer	0.000656	0.00219	CcSEcCtD
Maprotiline—DRD2—cerebellum—brain cancer	0.000654	0.00268	CbGeAlD
Maprotiline—Erythema multiforme—Etoposide—brain cancer	0.00065	0.00217	CcSEcCtD
Maprotiline—HTR2A—gonad—brain cancer	0.000648	0.00265	CbGeAlD
Maprotiline—Convulsion—Temozolomide—brain cancer	0.000648	0.00216	CcSEcCtD
Maprotiline—Hypertension—Temozolomide—brain cancer	0.000646	0.00216	CcSEcCtD
Maprotiline—Feeling abnormal—Hydroxyurea—brain cancer	0.000644	0.00215	CcSEcCtD
Maprotiline—Eye disorder—Etoposide—brain cancer	0.000642	0.00215	CcSEcCtD
Maprotiline—Vomiting—Procarbazine—brain cancer	0.000642	0.00214	CcSEcCtD
Maprotiline—Flushing—Etoposide—brain cancer	0.000638	0.00213	CcSEcCtD
Maprotiline—Cardiac disorder—Etoposide—brain cancer	0.000638	0.00213	CcSEcCtD
Maprotiline—Confusional state—Carmustine—brain cancer	0.000637	0.00213	CcSEcCtD
Maprotiline—Rash—Procarbazine—brain cancer	0.000636	0.00213	CcSEcCtD
Maprotiline—Dermatitis—Procarbazine—brain cancer	0.000636	0.00212	CcSEcCtD
Maprotiline—Anxiety—Temozolomide—brain cancer	0.000634	0.00212	CcSEcCtD
Maprotiline—HTR2A—pituitary gland—brain cancer	0.000633	0.00259	CbGeAlD
Maprotiline—Headache—Procarbazine—brain cancer	0.000632	0.00211	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000632	0.00211	CcSEcCtD
Maprotiline—Oedema—Carmustine—brain cancer	0.000631	0.00211	CcSEcCtD
Maprotiline—Infection—Carmustine—brain cancer	0.000627	0.0021	CcSEcCtD
Maprotiline—CYP1A2—endocrine gland—brain cancer	0.000627	0.00257	CbGeAlD
Maprotiline—Angiopathy—Etoposide—brain cancer	0.000624	0.00208	CcSEcCtD
Maprotiline—Dry mouth—Temozolomide—brain cancer	0.000623	0.00208	CcSEcCtD
Maprotiline—Mediastinal disorder—Etoposide—brain cancer	0.000619	0.00207	CcSEcCtD
Maprotiline—Thrombocytopenia—Carmustine—brain cancer	0.000618	0.00207	CcSEcCtD
Maprotiline—Body temperature increased—Hydroxyurea—brain cancer	0.000618	0.00206	CcSEcCtD
Maprotiline—Tachycardia—Carmustine—brain cancer	0.000616	0.00206	CcSEcCtD
Maprotiline—Confusional state—Temozolomide—brain cancer	0.000615	0.00206	CcSEcCtD
Maprotiline—HTR2A—medulla oblongata—brain cancer	0.00061	0.0025	CbGeAlD
Maprotiline—Oedema—Temozolomide—brain cancer	0.00061	0.00204	CcSEcCtD
Maprotiline—Alopecia—Etoposide—brain cancer	0.000607	0.00203	CcSEcCtD
Maprotiline—Infection—Temozolomide—brain cancer	0.000606	0.00202	CcSEcCtD
Maprotiline—Nausea—Procarbazine—brain cancer	0.0006	0.002	CcSEcCtD
Maprotiline—Nervous system disorder—Temozolomide—brain cancer	0.000598	0.002	CcSEcCtD
Maprotiline—Thrombocytopenia—Temozolomide—brain cancer	0.000598	0.002	CcSEcCtD
Maprotiline—Skin disorder—Temozolomide—brain cancer	0.000593	0.00198	CcSEcCtD
Maprotiline—CHRM3—brain—brain cancer	0.000591	0.00242	CbGeAlD
Maprotiline—Hypotension—Carmustine—brain cancer	0.00059	0.00197	CcSEcCtD
Maprotiline—Hyperhidrosis—Temozolomide—brain cancer	0.00059	0.00197	CcSEcCtD
Maprotiline—HRH1—endocrine gland—brain cancer	0.000587	0.0024	CbGeAlD
Maprotiline—Dysgeusia—Etoposide—brain cancer	0.000586	0.00196	CcSEcCtD
Maprotiline—SLC6A2—brain—brain cancer	0.000583	0.00239	CbGeAlD
Maprotiline—HRH1—head—brain cancer	0.000579	0.00237	CbGeAlD
Maprotiline—Insomnia—Carmustine—brain cancer	0.000571	0.00191	CcSEcCtD
Maprotiline—Paraesthesia—Carmustine—brain cancer	0.000567	0.00189	CcSEcCtD
Maprotiline—HTR7—brain—brain cancer	0.000562	0.0023	CbGeAlD
Maprotiline—Somnolence—Carmustine—brain cancer	0.000561	0.00188	CcSEcCtD
Maprotiline—Asthenia—Hydroxyurea—brain cancer	0.00056	0.00187	CcSEcCtD
Maprotiline—HTR2A—midbrain—brain cancer	0.000558	0.00228	CbGeAlD
Maprotiline—Insomnia—Temozolomide—brain cancer	0.000552	0.00184	CcSEcCtD
Maprotiline—Paraesthesia—Temozolomide—brain cancer	0.000548	0.00183	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Carmustine—brain cancer	0.000545	0.00182	CcSEcCtD
Maprotiline—HTR2A—spinal cord—brain cancer	0.000544	0.00223	CbGeAlD
Maprotiline—Somnolence—Temozolomide—brain cancer	0.000543	0.00181	CcSEcCtD
Maprotiline—Constipation—Carmustine—brain cancer	0.00054	0.0018	CcSEcCtD
Maprotiline—Dyspepsia—Temozolomide—brain cancer	0.000537	0.00179	CcSEcCtD
Maprotiline—Leukopenia—Etoposide—brain cancer	0.000536	0.00179	CcSEcCtD
Maprotiline—Diarrhoea—Hydroxyurea—brain cancer	0.000534	0.00179	CcSEcCtD
Maprotiline—DRD2—brain—brain cancer	0.000532	0.00218	CbGeAlD
Maprotiline—HRH1—central nervous system—brain cancer	0.000529	0.00216	CbGeAlD
Maprotiline—Gastrointestinal disorder—Temozolomide—brain cancer	0.000527	0.00176	CcSEcCtD
Maprotiline—Fatigue—Temozolomide—brain cancer	0.000526	0.00176	CcSEcCtD
Maprotiline—Loss of consciousness—Etoposide—brain cancer	0.000526	0.00176	CcSEcCtD
Maprotiline—Constipation—Temozolomide—brain cancer	0.000522	0.00174	CcSEcCtD
Maprotiline—Feeling abnormal—Carmustine—brain cancer	0.00052	0.00174	CcSEcCtD
Maprotiline—Convulsion—Etoposide—brain cancer	0.000518	0.00173	CcSEcCtD
Maprotiline—Hypertension—Etoposide—brain cancer	0.000517	0.00173	CcSEcCtD
Maprotiline—Dizziness—Hydroxyurea—brain cancer	0.000517	0.00173	CcSEcCtD
Maprotiline—Gastrointestinal pain—Carmustine—brain cancer	0.000516	0.00172	CcSEcCtD
Maprotiline—ABCB1—telencephalon—brain cancer	0.000509	0.00208	CbGeAlD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000506	0.00169	CcSEcCtD
Maprotiline—Feeling abnormal—Temozolomide—brain cancer	0.000503	0.00168	CcSEcCtD
Maprotiline—Abdominal pain—Carmustine—brain cancer	0.000499	0.00167	CcSEcCtD
Maprotiline—Body temperature increased—Carmustine—brain cancer	0.000499	0.00167	CcSEcCtD
Maprotiline—Gastrointestinal pain—Temozolomide—brain cancer	0.000499	0.00167	CcSEcCtD
Maprotiline—Vomiting—Hydroxyurea—brain cancer	0.000497	0.00166	CcSEcCtD
Maprotiline—Rash—Hydroxyurea—brain cancer	0.000493	0.00165	CcSEcCtD
Maprotiline—Confusional state—Etoposide—brain cancer	0.000492	0.00164	CcSEcCtD
Maprotiline—Dermatitis—Hydroxyurea—brain cancer	0.000492	0.00164	CcSEcCtD
Maprotiline—HTR2A—endocrine gland—brain cancer	0.00049	0.00201	CbGeAlD
Maprotiline—Headache—Hydroxyurea—brain cancer	0.000489	0.00163	CcSEcCtD
Maprotiline—Infection—Etoposide—brain cancer	0.000485	0.00162	CcSEcCtD
Maprotiline—Urticaria—Temozolomide—brain cancer	0.000485	0.00162	CcSEcCtD
Maprotiline—HTR2A—head—brain cancer	0.000484	0.00198	CbGeAlD
Maprotiline—Abdominal pain—Temozolomide—brain cancer	0.000482	0.00161	CcSEcCtD
Maprotiline—Body temperature increased—Temozolomide—brain cancer	0.000482	0.00161	CcSEcCtD
Maprotiline—Thrombocytopenia—Etoposide—brain cancer	0.000478	0.0016	CcSEcCtD
Maprotiline—Tachycardia—Etoposide—brain cancer	0.000477	0.00159	CcSEcCtD
Maprotiline—Skin disorder—Etoposide—brain cancer	0.000474	0.00158	CcSEcCtD
Maprotiline—Hyperhidrosis—Etoposide—brain cancer	0.000472	0.00158	CcSEcCtD
Maprotiline—Nausea—Hydroxyurea—brain cancer	0.000464	0.00155	CcSEcCtD
Maprotiline—Hypotension—Etoposide—brain cancer	0.000456	0.00152	CcSEcCtD
Maprotiline—Asthenia—Carmustine—brain cancer	0.000453	0.00151	CcSEcCtD
Maprotiline—CYP2D6—endocrine gland—brain cancer	0.000446	0.00183	CbGeAlD
Maprotiline—HTR2A—central nervous system—brain cancer	0.000442	0.00181	CbGeAlD
Maprotiline—CYP2D6—head—brain cancer	0.000441	0.0018	CbGeAlD
Maprotiline—Paraesthesia—Etoposide—brain cancer	0.000438	0.00146	CcSEcCtD
Maprotiline—Asthenia—Temozolomide—brain cancer	0.000438	0.00146	CcSEcCtD
Maprotiline—Somnolence—Etoposide—brain cancer	0.000434	0.00145	CcSEcCtD
Maprotiline—Diarrhoea—Carmustine—brain cancer	0.000432	0.00144	CcSEcCtD
Maprotiline—Pruritus—Temozolomide—brain cancer	0.000432	0.00144	CcSEcCtD
Maprotiline—HTR2A—cerebellum—brain cancer	0.000432	0.00177	CbGeAlD
Maprotiline—ABCB1—gonad—brain cancer	0.000425	0.00174	CbGeAlD
Maprotiline—Gastrointestinal disorder—Etoposide—brain cancer	0.000422	0.00141	CcSEcCtD
Maprotiline—Fatigue—Etoposide—brain cancer	0.000421	0.00141	CcSEcCtD
Maprotiline—HRH1—brain—brain cancer	0.00042	0.00172	CbGeAlD
Maprotiline—Dizziness—Carmustine—brain cancer	0.000418	0.00139	CcSEcCtD
Maprotiline—Constipation—Etoposide—brain cancer	0.000418	0.00139	CcSEcCtD
Maprotiline—Diarrhoea—Temozolomide—brain cancer	0.000418	0.00139	CcSEcCtD
Maprotiline—ABCB1—pituitary gland—brain cancer	0.000415	0.0017	CbGeAlD
Maprotiline—Dizziness—Temozolomide—brain cancer	0.000404	0.00135	CcSEcCtD
Maprotiline—Feeling abnormal—Etoposide—brain cancer	0.000402	0.00134	CcSEcCtD
Maprotiline—CYP2D6—central nervous system—brain cancer	0.000402	0.00165	CbGeAlD
Maprotiline—Vomiting—Carmustine—brain cancer	0.000402	0.00134	CcSEcCtD
Maprotiline—ABCB1—medulla oblongata—brain cancer	0.0004	0.00164	CbGeAlD
Maprotiline—Gastrointestinal pain—Etoposide—brain cancer	0.000399	0.00133	CcSEcCtD
Maprotiline—Rash—Carmustine—brain cancer	0.000398	0.00133	CcSEcCtD
Maprotiline—Dermatitis—Carmustine—brain cancer	0.000398	0.00133	CcSEcCtD
Maprotiline—Headache—Carmustine—brain cancer	0.000396	0.00132	CcSEcCtD
Maprotiline—CYP2D6—cerebellum—brain cancer	0.000393	0.00161	CbGeAlD
Maprotiline—Vomiting—Temozolomide—brain cancer	0.000388	0.0013	CcSEcCtD
Maprotiline—Urticaria—Etoposide—brain cancer	0.000388	0.0013	CcSEcCtD
Maprotiline—Abdominal pain—Etoposide—brain cancer	0.000386	0.00129	CcSEcCtD
Maprotiline—Body temperature increased—Etoposide—brain cancer	0.000386	0.00129	CcSEcCtD
Maprotiline—Rash—Temozolomide—brain cancer	0.000385	0.00129	CcSEcCtD
Maprotiline—Dermatitis—Temozolomide—brain cancer	0.000384	0.00128	CcSEcCtD
Maprotiline—Headache—Temozolomide—brain cancer	0.000382	0.00128	CcSEcCtD
Maprotiline—Nausea—Carmustine—brain cancer	0.000375	0.00125	CcSEcCtD
Maprotiline—ABCB1—midbrain—brain cancer	0.000366	0.0015	CbGeAlD
Maprotiline—Nausea—Temozolomide—brain cancer	0.000362	0.00121	CcSEcCtD
Maprotiline—ABCB1—spinal cord—brain cancer	0.000357	0.00146	CbGeAlD
Maprotiline—HTR2A—brain—brain cancer	0.000351	0.00144	CbGeAlD
Maprotiline—Asthenia—Etoposide—brain cancer	0.00035	0.00117	CcSEcCtD
Maprotiline—Pruritus—Etoposide—brain cancer	0.000345	0.00115	CcSEcCtD
Maprotiline—Diarrhoea—Etoposide—brain cancer	0.000334	0.00112	CcSEcCtD
Maprotiline—Dizziness—Etoposide—brain cancer	0.000323	0.00108	CcSEcCtD
Maprotiline—ABCB1—endocrine gland—brain cancer	0.000321	0.00131	CbGeAlD
Maprotiline—CYP2D6—brain—brain cancer	0.000319	0.00131	CbGeAlD
Maprotiline—ABCB1—head—brain cancer	0.000317	0.0013	CbGeAlD
Maprotiline—Vomiting—Etoposide—brain cancer	0.00031	0.00104	CcSEcCtD
Maprotiline—Rash—Etoposide—brain cancer	0.000308	0.00103	CcSEcCtD
Maprotiline—Dermatitis—Etoposide—brain cancer	0.000308	0.00103	CcSEcCtD
Maprotiline—Headache—Etoposide—brain cancer	0.000306	0.00102	CcSEcCtD
Maprotiline—Nausea—Etoposide—brain cancer	0.00029	0.000969	CcSEcCtD
Maprotiline—ABCB1—central nervous system—brain cancer	0.000289	0.00118	CbGeAlD
Maprotiline—ABCB1—cerebellum—brain cancer	0.000283	0.00116	CbGeAlD
Maprotiline—ABCB1—brain—brain cancer	0.00023	0.000941	CbGeAlD
Maprotiline—HTR2C—GPCR downstream signaling—PIK3CG—brain cancer	2.48e-05	0.000373	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—SHH—brain cancer	2.47e-05	0.000372	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TRPC6—brain cancer	2.46e-05	0.000371	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—HES1—brain cancer	2.44e-05	0.000368	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TRPC6—brain cancer	2.42e-05	0.000365	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—PTCH1—brain cancer	2.42e-05	0.000365	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—SMO—brain cancer	2.42e-05	0.000365	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TRPC6—brain cancer	2.42e-05	0.000364	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TRPC6—brain cancer	2.41e-05	0.000363	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TRPC6—brain cancer	2.4e-05	0.000362	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—IDH1—brain cancer	2.39e-05	0.00036	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—SMO—brain cancer	2.38e-05	0.000359	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—PTCH1—brain cancer	2.38e-05	0.000359	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TRPC6—brain cancer	2.38e-05	0.000359	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—PTCH1—brain cancer	2.38e-05	0.000358	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—SMO—brain cancer	2.38e-05	0.000358	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—SMO—brain cancer	2.37e-05	0.000357	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—PTCH1—brain cancer	2.37e-05	0.000357	CbGpPWpGaD
Maprotiline—HTR7—GPCR downstream signaling—IL2—brain cancer	2.36e-05	0.000356	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—PTCH1—brain cancer	2.36e-05	0.000356	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—SMO—brain cancer	2.36e-05	0.000356	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—SMO—brain cancer	2.34e-05	0.000352	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—PTCH1—brain cancer	2.34e-05	0.000352	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—PDGFRA—brain cancer	2.32e-05	0.00035	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—HES1—brain cancer	2.3e-05	0.000347	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—SPP1—brain cancer	2.25e-05	0.00034	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—IDH1—brain cancer	2.25e-05	0.00034	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—PIK3CG—brain cancer	2.25e-05	0.000339	CbGpPWpGaD
Maprotiline—CHRM4—GPCR downstream signaling—IL2—brain cancer	2.23e-05	0.000336	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—BSG—brain cancer	2.22e-05	0.000335	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—HES1—brain cancer	2.21e-05	0.000332	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—NOTCH2—brain cancer	2.19e-05	0.000331	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—PDGFRA—brain cancer	2.19e-05	0.000331	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—PIK3CG—brain cancer	2.18e-05	0.000329	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—PIK3CG—brain cancer	2.15e-05	0.000324	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—IL2—brain cancer	2.15e-05	0.000323	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—PIK3CG—brain cancer	2.14e-05	0.000323	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—PIK3CG—brain cancer	2.14e-05	0.000322	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—IL2—brain cancer	2.14e-05	0.000322	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—PIK3CG—brain cancer	2.13e-05	0.000321	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—SPP1—brain cancer	2.13e-05	0.000321	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—PIK3CG—brain cancer	2.11e-05	0.000318	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	2.11e-05	0.000318	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—PDGFRA—brain cancer	2.1e-05	0.000317	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—VAV1—brain cancer	2.09e-05	0.000315	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—SPP1—brain cancer	2.04e-05	0.000307	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—IRS2—brain cancer	2.04e-05	0.000307	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—IL2—brain cancer	2.03e-05	0.000305	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—PIK3CG—brain cancer	1.98e-05	0.000299	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—PIK3CG—brain cancer	1.95e-05	0.000294	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—PIK3CG—brain cancer	1.95e-05	0.000293	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—PIK3CG—brain cancer	1.94e-05	0.000293	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—IL2—brain cancer	1.94e-05	0.000292	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—NOTCH2—brain cancer	1.94e-05	0.000292	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—PIK3CG—brain cancer	1.94e-05	0.000292	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IRS2—brain cancer	1.93e-05	0.00029	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—PIK3CG—brain cancer	1.92e-05	0.000289	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—IDH1—brain cancer	1.91e-05	0.000288	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—NOTCH2—brain cancer	1.9e-05	0.000287	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—NOTCH2—brain cancer	1.9e-05	0.000286	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—NOTCH2—brain cancer	1.89e-05	0.000285	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—ENO2—brain cancer	1.89e-05	0.000285	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—NOTCH2—brain cancer	1.89e-05	0.000285	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—NOTCH2—brain cancer	1.87e-05	0.000282	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—VAV1—brain cancer	1.85e-05	0.000278	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IRS2—brain cancer	1.84e-05	0.000278	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—VAV1—brain cancer	1.82e-05	0.000274	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—VAV1—brain cancer	1.81e-05	0.000273	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—VAV1—brain cancer	1.81e-05	0.000272	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—APC—brain cancer	1.8e-05	0.000271	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—PIK3CG—brain cancer	1.8e-05	0.000271	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—VAV1—brain cancer	1.8e-05	0.000271	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—HES1—brain cancer	1.8e-05	0.000271	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—VAV1—brain cancer	1.78e-05	0.000269	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—ENO2—brain cancer	1.78e-05	0.000268	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—IL2—brain cancer	1.74e-05	0.000262	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—PDGFRA—brain cancer	1.71e-05	0.000258	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—PIK3CG—brain cancer	1.7e-05	0.000256	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—APC—brain cancer	1.7e-05	0.000256	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—SPP1—brain cancer	1.66e-05	0.00025	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—EGFR—brain cancer	1.64e-05	0.000247	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—APC—brain cancer	1.63e-05	0.000245	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—PIK3CG—brain cancer	1.63e-05	0.000245	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—HES1—brain cancer	1.59e-05	0.000239	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—IL2—brain cancer	1.58e-05	0.000238	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—HES1—brain cancer	1.56e-05	0.000235	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—HES1—brain cancer	1.56e-05	0.000235	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.55e-05	0.000234	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—HES1—brain cancer	1.55e-05	0.000234	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—EGFR—brain cancer	1.55e-05	0.000233	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—HES1—brain cancer	1.55e-05	0.000233	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—IL2—brain cancer	1.54e-05	0.000232	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—HES1—brain cancer	1.53e-05	0.000231	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—IL2—brain cancer	1.51e-05	0.000228	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—PDGFRA—brain cancer	1.51e-05	0.000228	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—ENO2—brain cancer	1.51e-05	0.000227	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—IL2—brain cancer	1.51e-05	0.000227	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—IL2—brain cancer	1.5e-05	0.000227	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IRS2—brain cancer	1.5e-05	0.000227	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—IL2—brain cancer	1.5e-05	0.000226	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—PDGFRA—brain cancer	1.49e-05	0.000224	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—IL2—brain cancer	1.48e-05	0.000224	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—EGFR—brain cancer	1.48e-05	0.000224	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—PDGFRA—brain cancer	1.48e-05	0.000224	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—PDGFRA—brain cancer	1.48e-05	0.000223	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—PDGFRA—brain cancer	1.47e-05	0.000222	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—SPP1—brain cancer	1.47e-05	0.000221	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—PDGFRA—brain cancer	1.46e-05	0.00022	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—SPP1—brain cancer	1.44e-05	0.000218	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—SPP1—brain cancer	1.44e-05	0.000217	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—SPP1—brain cancer	1.44e-05	0.000216	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—SPP1—brain cancer	1.43e-05	0.000216	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—SPP1—brain cancer	1.42e-05	0.000214	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—RELA—brain cancer	1.41e-05	0.000212	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—ERBB2—brain cancer	1.4e-05	0.000211	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—IL2—brain cancer	1.4e-05	0.00021	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—IL2—brain cancer	1.37e-05	0.000207	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—IL2—brain cancer	1.37e-05	0.000207	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—PIK3CG—brain cancer	1.37e-05	0.000206	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—IL2—brain cancer	1.37e-05	0.000206	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—IL2—brain cancer	1.36e-05	0.000205	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—IL2—brain cancer	1.35e-05	0.000203	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—RELA—brain cancer	1.33e-05	0.0002	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—PIK3CG—brain cancer	1.33e-05	0.0002	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—APC—brain cancer	1.33e-05	0.0002	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IRS2—brain cancer	1.33e-05	0.0002	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—ERBB2—brain cancer	1.32e-05	0.000199	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IRS2—brain cancer	1.31e-05	0.000197	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IRS2—brain cancer	1.3e-05	0.000196	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IRS2—brain cancer	1.3e-05	0.000196	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IRS2—brain cancer	1.29e-05	0.000195	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IRS2—brain cancer	1.28e-05	0.000193	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—RELA—brain cancer	1.27e-05	0.000192	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—IL2—brain cancer	1.27e-05	0.000191	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—ERBB2—brain cancer	1.26e-05	0.000191	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CCND1—brain cancer	1.24e-05	0.000186	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CTNNB1—brain cancer	1.22e-05	0.000184	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—EGFR—brain cancer	1.21e-05	0.000182	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IL2—brain cancer	1.2e-05	0.00018	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—PIK3CG—brain cancer	1.17e-05	0.000177	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—APC—brain cancer	1.17e-05	0.000177	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CCND1—brain cancer	1.17e-05	0.000176	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CTNNB1—brain cancer	1.16e-05	0.000174	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—PIK3CG—brain cancer	1.15e-05	0.000174	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—APC—brain cancer	1.15e-05	0.000174	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—APC—brain cancer	1.15e-05	0.000173	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—PIK3CG—brain cancer	1.15e-05	0.000173	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—APC—brain cancer	1.15e-05	0.000173	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—PIK3CG—brain cancer	1.15e-05	0.000173	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IL2—brain cancer	1.15e-05	0.000173	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—PIK3CG—brain cancer	1.14e-05	0.000172	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—APC—brain cancer	1.14e-05	0.000172	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—PIK3CG—brain cancer	1.13e-05	0.000171	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—APC—brain cancer	1.13e-05	0.000171	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CCND1—brain cancer	1.12e-05	0.000168	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CTNNB1—brain cancer	1.11e-05	0.000167	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—VEGFA—brain cancer	1.08e-05	0.000162	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—EGFR—brain cancer	1.07e-05	0.000161	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—STAT3—brain cancer	1.07e-05	0.000161	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—EGFR—brain cancer	1.05e-05	0.000158	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—EGFR—brain cancer	1.05e-05	0.000158	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—EGFR—brain cancer	1.04e-05	0.000157	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—EGFR—brain cancer	1.04e-05	0.000157	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—RELA—brain cancer	1.04e-05	0.000156	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—EGFR—brain cancer	1.03e-05	0.000155	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—ERBB2—brain cancer	1.03e-05	0.000155	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—VEGFA—brain cancer	1.02e-05	0.000153	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—STAT3—brain cancer	1.01e-05	0.000152	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—MYC—brain cancer	9.91e-06	0.000149	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—VEGFA—brain cancer	9.74e-06	0.000147	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—EGFR—brain cancer	9.69e-06	0.000146	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—STAT3—brain cancer	9.64e-06	0.000145	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—MYC—brain cancer	9.36e-06	0.000141	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IL2—brain cancer	9.34e-06	0.000141	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—RELA—brain cancer	9.16e-06	0.000138	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—EGFR—brain cancer	9.15e-06	0.000138	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CCND1—brain cancer	9.11e-06	0.000137	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—ERBB2—brain cancer	9.1e-06	0.000137	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CTNNB1—brain cancer	9.02e-06	0.000136	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—RELA—brain cancer	9.01e-06	0.000136	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—RELA—brain cancer	8.99e-06	0.000135	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—MYC—brain cancer	8.96e-06	0.000135	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—RELA—brain cancer	8.96e-06	0.000135	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—ERBB2—brain cancer	8.95e-06	0.000135	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—ERBB2—brain cancer	8.93e-06	0.000135	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—RELA—brain cancer	8.93e-06	0.000135	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—ERBB2—brain cancer	8.9e-06	0.000134	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—ERBB2—brain cancer	8.88e-06	0.000134	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—RELA—brain cancer	8.85e-06	0.000133	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—ERBB2—brain cancer	8.79e-06	0.000132	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—EGFR—brain cancer	8.77e-06	0.000132	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PIK3CG—brain cancer	8.67e-06	0.000131	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IL2—brain cancer	8.25e-06	0.000124	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PIK3CG—brain cancer	8.17e-06	0.000123	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—TP53—brain cancer	8.14e-06	0.000123	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IL2—brain cancer	8.11e-06	0.000122	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IL2—brain cancer	8.1e-06	0.000122	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IL2—brain cancer	8.07e-06	0.000122	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IL2—brain cancer	8.04e-06	0.000121	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CCND1—brain cancer	8.04e-06	0.000121	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IL2—brain cancer	7.97e-06	0.00012	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CTNNB1—brain cancer	7.96e-06	0.00012	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—VEGFA—brain cancer	7.94e-06	0.00012	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CCND1—brain cancer	7.91e-06	0.000119	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CCND1—brain cancer	7.89e-06	0.000119	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CCND1—brain cancer	7.87e-06	0.000119	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—STAT3—brain cancer	7.86e-06	0.000118	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CCND1—brain cancer	7.84e-06	0.000118	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CTNNB1—brain cancer	7.83e-06	0.000118	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CTNNB1—brain cancer	7.82e-06	0.000118	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CTNNB1—brain cancer	7.79e-06	0.000117	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CCND1—brain cancer	7.77e-06	0.000117	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CTNNB1—brain cancer	7.77e-06	0.000117	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CTNNB1—brain cancer	7.69e-06	0.000116	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—TP53—brain cancer	7.69e-06	0.000116	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—TP53—brain cancer	7.36e-06	0.000111	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—MYC—brain cancer	7.31e-06	0.00011	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—EGFR—brain cancer	7.15e-06	0.000108	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—VEGFA—brain cancer	7.01e-06	0.000106	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—STAT3—brain cancer	6.94e-06	0.000105	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PIK3CG—brain cancer	6.92e-06	0.000104	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—VEGFA—brain cancer	6.9e-06	0.000104	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—VEGFA—brain cancer	6.88e-06	0.000104	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—VEGFA—brain cancer	6.86e-06	0.000103	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—VEGFA—brain cancer	6.84e-06	0.000103	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—STAT3—brain cancer	6.83e-06	0.000103	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—STAT3—brain cancer	6.81e-06	0.000103	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—STAT3—brain cancer	6.79e-06	0.000102	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—VEGFA—brain cancer	6.77e-06	0.000102	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—STAT3—brain cancer	6.77e-06	0.000102	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—STAT3—brain cancer	6.7e-06	0.000101	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—MYC—brain cancer	6.45e-06	9.72e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—MYC—brain cancer	6.34e-06	9.56e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MYC—brain cancer	6.33e-06	9.54e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MYC—brain cancer	6.31e-06	9.51e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—EGFR—brain cancer	6.31e-06	9.5e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MYC—brain cancer	6.29e-06	9.48e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MYC—brain cancer	6.23e-06	9.39e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—EGFR—brain cancer	6.21e-06	9.35e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—EGFR—brain cancer	6.19e-06	9.33e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—EGFR—brain cancer	6.17e-06	9.3e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—EGFR—brain cancer	6.15e-06	9.27e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—EGFR—brain cancer	6.09e-06	9.18e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TP53—brain cancer	6e-06	9.04e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TP53—brain cancer	5.29e-06	7.98e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TP53—brain cancer	5.21e-06	7.85e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TP53—brain cancer	5.2e-06	7.83e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TP53—brain cancer	5.18e-06	7.81e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TP53—brain cancer	5.17e-06	7.78e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TP53—brain cancer	5.12e-06	7.71e-05	CbGpPWpGaD
